Study of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at Santa Monica, California and other locations
- Dates
- study startedcompletion around
- Principal Investigator
- by Zev A. Wainberg, MD

Description
Summary
Official Title
Keywords
Eligibility
Locations
Lead Scientist at UCLA
- Zev A. Wainberg, MD
Zev Wainberg, M.D., holds the Estelle, Abe, and Marjorie Sanders Chair in Cancer Research.
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Arcus Biosciences, Inc.
- Links
- PRISM-1 - Public website Sign up for this study
- ID
- NCT06608927
- Phase
- Phase 3 Pancreatic Ductal Adenocarcinoma Research Study
- Study Type
- Interventional
- Participants
- Expecting 610 study participants
- Last Updated